Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Intrinsic cooperativity potentiates parallel cis-regulatory evolution.

Sorrells TR, Johnson AN, Howard CJ, Britton CS, Fowler KR, Feigerle JT, Weil PA, Johnson AD.

Elife. 2018 Sep 10;7. pii: e37563. doi: 10.7554/eLife.37563.

2.

Identification of a transcriptional activation domain in yeast repressor activator protein 1 (Rap1) using an altered DNA-binding specificity variant.

Johnson AN, Weil PA.

J Biol Chem. 2017 Apr 7;292(14):5705-5723. doi: 10.1074/jbc.M117.779181. Epub 2017 Feb 14.

4.

Suppression of intragenic transcription requires the MOT1 and NC2 regulators of TATA-binding protein.

Koster MJ, Yildirim AD, Weil PA, Holstege FC, Timmers HT.

Nucleic Acids Res. 2014 Apr;42(7):4220-9. doi: 10.1093/nar/gkt1398. Epub 2014 Jan 22.

5.

Direct TFIIA-TFIID protein contacts drive budding yeast ribosomal protein gene transcription.

Layer JH, Weil PA.

J Biol Chem. 2013 Aug 9;288(32):23273-94. doi: 10.1074/jbc.M113.486829. Epub 2013 Jun 27.

6.

A novel algorithm for validating peptide identification from a shotgun proteomics search engine.

Jian L, Niu X, Xia Z, Samir P, Sumanasekera C, Mu Z, Jennings JL, Hoek KL, Allos T, Howard LM, Edwards KM, Weil PA, Link AJ.

J Proteome Res. 2013 Mar 1;12(3):1108-19. doi: 10.1021/pr300631t. Epub 2013 Feb 12.

7.

Examining the code. ACHE's Code of Ethics highlights challenges faced by healthcare leaders.

Bowen DJ, Weil PA.

Healthc Exec. 2011 Jul-Aug;26(4):39-42, 44. No abstract available.

PMID:
21826845
8.

New insights into the function of transcription factor TFIID from recent structural studies.

Papai G, Weil PA, Schultz P.

Curr Opin Genet Dev. 2011 Apr;21(2):219-24. doi: 10.1016/j.gde.2011.01.009. Epub 2011 Mar 21. Review.

9.

TFIIA and the transactivator Rap1 cooperate to commit TFIID for transcription initiation.

Papai G, Tripathi MK, Ruhlmann C, Layer JH, Weil PA, Schultz P.

Nature. 2010 Jun 17;465(7300):956-60. doi: 10.1038/nature09080.

10.

The volunteer activities of healthcare executives.

Weil PA, Kimball PA.

J Healthc Manag. 2010 Mar-Apr;55(2):115-29; discussion 129-31.

PMID:
20402367
11.

Direct transactivator-transcription factor IID (TFIID) contacts drive yeast ribosomal protein gene transcription.

Layer JH, Miller SG, Weil PA.

J Biol Chem. 2010 May 14;285(20):15489-99. doi: 10.1074/jbc.M110.104810. Epub 2010 Feb 26.

12.
13.

Mapping the initiator binding Taf2 subunit in the structure of hydrated yeast TFIID.

Papai G, Tripathi MK, Ruhlmann C, Werten S, Crucifix C, Weil PA, Schultz P.

Structure. 2009 Mar 11;17(3):363-73. doi: 10.1016/j.str.2009.01.006.

14.
15.

A proteomics analysis of yeast Mot1p protein-protein associations: insights into mechanism.

Arnett DR, Jennings JL, Tabb DL, Link AJ, Weil PA.

Mol Cell Proteomics. 2008 Nov;7(11):2090-106. doi: 10.1074/mcp.M800221-MCP200. Epub 2008 Jul 2.

16.

The transcriptional repressor activator protein Rap1p is a direct regulator of TATA-binding protein.

Bendjennat M, Weil PA.

J Biol Chem. 2008 Mar 28;283(13):8699-710. doi: 10.1074/jbc.M709436200. Epub 2008 Jan 14.

17.

Narrowing the gender gap in healthcare management.

Weil PA, Zimmerman M.

Healthc Exec. 2007 May-Jun;22(3):22-4, 26, 28-30. No abstract available.

PMID:
17523348
18.

The prevalence and impact of disability among healthcare executives.

Lerner WM, Weil PA, Kirschner KL.

Healthc Exec. 2006 Nov-Dec;21(6):24-6, 28-9. No abstract available.

PMID:
17121102
19.

Yeast TFIID serves as a coactivator for Rap1p by direct protein-protein interaction.

Garbett KA, Tripathi MK, Cencki B, Layer JH, Weil PA.

Mol Cell Biol. 2007 Jan;27(1):297-311. Epub 2006 Oct 30.

20.

Cluster analysis of mass spectrometry data reveals a novel component of SAGA.

Powell DW, Weaver CM, Jennings JL, McAfee KJ, He Y, Weil PA, Link AJ.

Mol Cell Biol. 2004 Aug;24(16):7249-59.

21.

Molecular and genetic characterization of a Taf1p domain essential for yeast TFIID assembly.

Singh MV, Bland CE, Weil PA.

Mol Cell Biol. 2004 Jun;24(11):4929-42.

22.

Mapping key functional sites within yeast TFIID.

Leurent C, Sanders SL, Demény MA, Garbett KA, Ruhlmann C, Weil PA, Tora L, Schultz P.

EMBO J. 2004 Feb 25;23(4):719-27. Epub 2004 Feb 12.

23.

To shatter the glass ceiling in healthcare management: who supports affirmative action and why?

Weil PA, Mattis MC.

Health Serv Manage Res. 2003 Nov;16(4):224-33.

PMID:
14613620
24.

A race/ethnic comparison of career attainments in healthcare management.

Weil PA.

Healthc Exec. 2003 Nov-Dec;18(6):22-7. No abstract available.

PMID:
14603807
25.
26.

Use of a genetically introduced cross-linker to identify interaction sites of acidic activators within native transcription factor IID and SAGA.

Klein J, Nolden M, Sanders SL, Kirchner J, Weil PA, Melcher K.

J Biol Chem. 2003 Feb 28;278(9):6779-86. Epub 2002 Dec 24.

27.

Mot1p is essential for TBP recruitment to selected promoters during in vivo gene activation.

Andrau JC, Van Oevelen CJ, Van Teeffelen HA, Weil PA, Holstege FC, Timmers HT.

EMBO J. 2002 Oct 1;21(19):5173-83.

28.

Functional analysis of the TFIID-specific yeast TAF4 (yTAF(II)48) reveals an unexpected organization of its histone-fold domain.

Thuault S, Gangloff YG, Kirchner J, Sanders S, Werten S, Romier C, Weil PA, Davidson I.

J Biol Chem. 2002 Nov 22;277(47):45510-7. Epub 2002 Sep 16.

29.

Molecular characterization of Saccharomyces cerevisiae TFIID.

Sanders SL, Garbett KA, Weil PA.

Mol Cell Biol. 2002 Aug;22(16):6000-13.

30.

A method for plasmid purification directly from yeast.

Singh MV, Weil PA.

Anal Biochem. 2002 Aug 1;307(1):13-7.

PMID:
12137773
31.

Mapping histone fold TAFs within yeast TFIID.

Leurent C, Sanders S, Ruhlmann C, Mallouh V, Weil PA, Kirschner DB, Tora L, Schultz P.

EMBO J. 2002 Jul 1;21(13):3424-33.

32.
33.

Distinct mutations in yeast TAF(II)25 differentially affect the composition of TFIID and SAGA complexes as well as global gene expression patterns.

Kirschner DB, vom Baur E, Thibault C, Sanders SL, Gangloff YG, Davidson I, Weil PA, Tora L.

Mol Cell Biol. 2002 May;22(9):3178-93.

34.

Narrowing the gender gap in healthcare management.

Weil PA, Mattis MC.

Healthc Exec. 2001 Nov-Dec;16(6):12-7. No abstract available.

PMID:
11702423
35.

Fluorescence-based analyses of the effects of full-length recombinant TAF130p on the interaction of TATA box-binding protein with TATA box DNA.

Banik U, Beechem JM, Klebanow E, Schroeder S, Weil PA.

J Biol Chem. 2001 Dec 28;276(52):49100-9. Epub 2001 Oct 24.

36.
37.

Histone folds mediate selective heterodimerization of yeast TAF(II)25 with TFIID components yTAF(II)47 and yTAF(II)65 and with SAGA component ySPT7.

Gangloff YG, Sanders SL, Romier C, Kirschner D, Weil PA, Tora L, Davidson I.

Mol Cell Biol. 2001 Mar;21(5):1841-53.

38.

Affiliates' thoughts on critical pathways.

Weil PA.

Healthc Exec. 2000 Nov-Dec;15(6):42-3. No abstract available.

PMID:
11185367
39.
40.

Motivating community health improvement: leading practices you can use.

Weil PA, Bogue RJ.

Healthc Exec. 1999 Nov-Dec;14(6):18-24. No abstract available.

PMID:
10623155
41.
43.
44.

ADR1-mediated transcriptional activation requires the presence of an intact TFIID complex.

Komarnitsky PB, Klebanow ER, Weil PA, Denis CL.

Mol Cell Biol. 1998 Oct;18(10):5861-7.

46.
47.

The Gcn4p activation domain interacts specifically in vitro with RNA polymerase II holoenzyme, TFIID, and the Adap-Gcn5p coactivator complex.

Drysdale CM, Jackson BM, McVeigh R, Klebanow ER, Bai Y, Kokubo T, Swanson M, Nakatani Y, Weil PA, Hinnebusch AG.

Mol Cell Biol. 1998 Mar;18(3):1711-24.

Supplemental Content

Support Center